Interested In Exhibiting?

Subscribe to our E-magazine

More detail

The Medical Imaging Convention the UK’s dedicated event that offers a comprehensive program on the latest innovations in imaging diagnosis and treatment, to UK-based medical imaging professionals and their senior management teams. The event provides the most up-to-date research, data and developments that can enable better patient outcomes, efficiency and cost-effectiveness in UK medical imaging.

Medical Imaging Convention runs alongside:

When Is The Show?

6th to 7th June 2018, ExCeL London

Doors: 10AM - 5PM

Sanjay Prabhu, MBBS

Harvard Medical School / Boston Children’s Hospital

Sanjay Prabhu is a Staff Pediatric Neuroradiologist at Boston Children''''s Hospital and Assistant Professor of Radiology at the Harvard Medical School. He is the Director of the Advanced Image Analysis Lab at Boston Children’s Hospital and Clinical Director of the SIMPeds3D print program.

His current clinical research interests include 3D printing, imaging of pediatric epilepsy, use of augmented reality, clinical decision support, and machine learning in radiology. He has authored more than 100 peer-reviewed papers and 15 book chapters.

As part of his work in the SIMPeds3D print program, he is focused on evaluating utility of 3D printed models, virtual surgery, augmented and mixed reality and rapid prototyping for pediatric surgical simulation and education. With his team at SIMPeds3D print, he has helped create more than 450 bespoke 3D patient specific models to help clinicians from various subspecialties in Boston and other parts of the world.

Share this

Evolving role of machine learning in brain tumour imaging

In this talk, I will discuss the role of machine learning in the acquisition and interpretation of imaging studies performed in children with brain tumours. Topics explored will include areas where tumour imaging is best interpreted by a machine, situations where a machine can put together information from multiple sources and inform the radiologist to make a better interpretation, and role of machine learning in correlating imaging findings to the genetic make up of the tumour and treatment options. Many of these topics are currently in the research realm but will revolutionise treatment of brain (and other) tumours in the next decade.